secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0000950170-22-011747
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcus Biosciences revises non-employee director compensation, effective June 14, 2022
--------------------------------------------------------------------------------

- Annual cash retainer set at $45,000 per director; additional retainers for lead independent director ($5,000) and committee chairs/members.
- Initial equity award with ~$625,000 grant date fair value, split 2/3 stock options and 1/3 RSUs, vesting over 3 years.
- Annual equity award with ~$350,000 grant date fair value, same option/RSU split, vesting fully after 12 months or next annual meeting.
- All equity vests fully upon a change in control; new directors do not receive an annual award in the same calendar year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000095017022011747/0000950170-22-011747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000095017022011747/rcus-20220614.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer